vanA-consistent phenotype vancomycin-resistant enterococcal colonization is associated with inferior overall survival in acute myeloid leukemia patients undergoing intensive chemotherapy: a single-center retrospective study
Infection · 2026-08 · 54 (4) · 2075-2084
DOI: 10.1007/s15010-026-02836-5 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection, online erschienen am 28.05.2026. Verfasst von Sebastian Wolf und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine 2, Hematology and Oncology, University Hospital, Goethe-University Frankfurt, Frankfurt am Main, Germany. wolf@med.uni-frankfu…. Hauptthemen laut MEDLINE: Leukemia, Myeloid, Acute, Vancomycin-Resistant Enterococci, Gram-Positive Bacterial Infections, Bacterial Proteins. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Johann Wolfgang Goethe-Universität, Frankfurt am Main.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Vancomycin-resistant enterococci (VRE) colonization is common among patients with acute myeloid leukemia (AML) undergoing intensive chemotherapy. Whether the teicoplanin-defined VRE phenotype, specifically vanA- consistent (teicoplanin-resistant) versus vanB -consistent (teicoplanin-susceptible), is associated with adverse outcomes is unknown.
Methods
We conducted a retrospective single-center cohort study of 192 VRE-colonized AML patients who received intensive induction chemotherapy between 2015 and 2024. vanA- consistent phenotype ( n = 35, 18.2%) was defined as VRE isolates demonstrating vancomycin (MIC > 4 mg/l) and teicoplanin resistance (MIC > 2 mg/L). vanB -consistent phenotype ( n = 157, 81.8%) was defined as VRE isolates susceptible to teicoplanin. The primary endpoint was overall survival (OS). Cox proportional hazards regression estimated the association between VRE phenotype and OS with adjustment for ELN 2022 genetic risk, sex, ECOG performance status, and allogeneic stem cell transplantation. Healthcare-exposure variables were compared between phenotypes, and the interaction between vanA -consistent phenotype and cumulative inpatient days before VRE detection was evaluated. Results vanA -consistent phenotype patients had significantly inferior OS compared with vanB -consistent phenotype patients (3-year OS 46.1% vs. 73.2%; log-rank p = 0.004). vanA- consistent phenotype was strongly associated with adverse-risk ELN 2022 genetics (54% vs. 24%; OR 3.69, p < 0.001). Despite this association, vanA -consistent phenotype remained associated with OS after adjustment for ELN 2022 risk, sex, ECOG, and allo-SCT (HR 1.85, 95% CI 1.03–3.34, p = 0.041). The vanA -associated hazard increased with longer cumulative inpatient exposure before VRE detection. No significant differences were observed for infection-related complications between vanA- and vanB- consistent phenotypes. Conclusions vanA -consistent phenotype VRE colonization is an adverse prognostic factor in VRE-colonized AML patients, providing prognostic information beyond ELN 2022 genetic risk classification. To our knowledge, this is the first study to demonstrate differential outcomes by teicoplanin-defined VRE phenotype. Despite enrichment for adverse-risk genetics in vanA -consistent phenotype patients, this did not fully account for the survival disadvantage. Prospective multicenter validation is warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine 2, Hematology and Oncology, University Hospital, Goethe-University Frankfurt, Frankfurt am Main, Germany. wolf@med.uni-frankfurt.de.
- Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany. wolf@med.uni-frankfurt.de.
- German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, A Partnership Between DKFZ and University Hospital Frankfurt, Frankfurt am Main, Germany. wolf@med.uni-frankfurt.de.
- University Cancer Center (UCT), University Hospital, Goethe-University Frankfurt, Frankfurt am Main, Germany. wolf@med.uni-frankfurt.de.
- Department of Medicine 2, Hematology and Oncology, University Hospital, Goethe-University Frankfurt, Frankfurt am Main, Germany.
- Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany.
Förderung
- Johann Wolfgang Goethe-Universität, Frankfurt am Main
Zitieren
APA
Wolf, S., Zeltner, N., Henze, N., Enssle, J. C., Kempf, V. A. J., Kessel, J., Vehreschild, M. J. G. T., Steffen, B., Oellerich, T., Serve, H., Hogardt, M., & Scheich, S. (2026). vanA-consistent phenotype vancomycin-resistant enterococcal colonization is associated with inferior overall survival in acute myeloid leukemia patients undergoing intensive chemotherapy: a single-center retrospective study. Infection, 54(4), 2075-2084. https://doi.org/10.1007/s15010-026-02836-5
Vancouver
Wolf S, Zeltner N, Henze N, Enssle JC, Kempf VAJ, Kessel J, et al. vanA-consistent phenotype vancomycin-resistant enterococcal colonization is associated with inferior overall survival in acute myeloid leukemia patients undergoing intensive chemotherapy: a single-center retrospective study. Infection. 2026;54(4):2075-2084. doi:10.1007/s15010-026-02836-5
BibTeX
@article{Wolf2026,
author = {Wolf, Sebastian and Zeltner, Nico and Henze, Nele and Enssle, Julius C and Kempf, Volkhard A J and Kessel, Johanna and Vehreschild, Maria J G T and Steffen, Björn and Oellerich, Thomas and Serve, Hubert and Hogardt, Michael and Scheich, Sebastian},
title = {vanA-consistent phenotype vancomycin-resistant enterococcal colonization is associated with inferior overall survival in acute myeloid leukemia patients undergoing intensive chemotherapy: a single-center retrospective study},
journal = {Infection},
year = {2026},
volume = {54},
number = {4},
pages = {2075--2084},
doi = {10.1007/s15010-026-02836-5}
}
EUVIMED